Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Contributions of prion strains and substrains to prion zoonotic potential and evolution

Award Number: R01NS133050
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2023
PERIOD OF PERFORMANCE END DATE: 06/30/2028

Group Awards By:

View Award Description

Contributions of prion strains and substrains to prion zoonotic potential and evolution - Prions are infectious protein-only zoonotic agents that can rapidly evolve in a new replication environment. Prion strains are encoded by strain-specific conformations of PrPSc, the infectious form of the host-encoded prion protein, PrPC. Collinge and Clarke hypothesized that prion strains are a mixture of a dominant prion strain and substrains. In support of this hypothesis, we and others have shown: i) treatment of prions with anti-prion drugs can result in the emergence of a drug resistant strain, ii) physical methods (e.g. thermostability) that partially inactivate prions can select for prions with altered strain properties, and iii) strains within a given host species can have different host ranges. Despite these data, direct evidence for the existence of preexisting substrains is lacking and, consequently, the contributions of substrains to prion evolution has not been explored. The long-term goal of this work is to prevent prion evolution to a new replicative environment. The overall objective of this application is to determine the relative contributions of the dominant prion strain and substrains to interspecies transmission of prions. In this application we will test the hypothesis is that prion substrains drive prion transmission to a new PrP genotype. The hypothesis is based on our new discovery that selective reduction of PrPSc from the biologically cloned hamster-adapted drowsy (DY) strain of transmissible mink encephalopathy (TME), using two mechanistically different methods, allows for the emergence and isolation of a preexisting substrain that is distinct from DY. Moreover, this substrain unexpectedly has a different host range than DY TME. To test our hypothesis, we will first explore the frequency and diversity of preexisting substrains from stable and unstable prion strains using complimentary methods (conformational stability, protease digestion, thermostability) to selectively depopulate the dominant strain. The frequency and diversity of substrains isolated will be determined using complementary in vitro prion detection methods and animal bioassay. Second, we will explore the well-studied hamster/mouse species barrier using complementary in vitro and in vivo methods to determine the relative contributions of the dominant strain and substrains to interspecies transmission. The concept of strain interference between the dominant strain and substrains will be tested in regards interspecies transmission. These studies are significant since it is critical to understand the contributions of substrains to prion evolution as current prion treatment methods in development (vaccination, anti-prion drugs, environmental mitigation procedures) target the dominant strain. It is therefore possible that these methods will inadvertently result in the emergence of preexisting prion strains with altered zoonotic potential and/or increased pathogenicity. Overall, these studies will directly test the Collinge and Clark model of prion strain dynamics and will allow for a more precise evaluation potential of prion strains to adapt to a new replication environment (e.g., chronic wasting disease transmission to humans).


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $546,705 )
2026	2026	CREIGHTON UNIVERSITY	2500 CALIFORNIA PLAZA	OMAHA	NE	68178	DOUGLAS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	4	7/16/2026	NON-COMPETING CONTINUATION	$546,705
														Subtotal = $546,705

Issue Date FY: 2025 ( Subtotal = $544,279 )
2025	2025	CREIGHTON UNIVERSITY	2500 CALIFORNIA PLAZA	OMAHA	NE	68178	DOUGLAS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	3	7/14/2025	NON-COMPETING CONTINUATION	$544,279
														Subtotal = $544,279

Issue Date FY: 2024 ( Subtotal = $527,952 )
2024	2024	CREIGHTON UNIVERSITY	2500 CALIFORNIA PLAZA	OMAHA	NE	68178	DOUGLAS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	6/14/2024	NON-COMPETING CONTINUATION	$527,952
														Subtotal = $527,952

Issue Date FY: 2023 ( Subtotal = $581,891 )
2023	2023	CREIGHTON UNIVERSITY	2500 CALIFORNIA PLAZA	OMAHA	NE	68178	DOUGLAS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	6/2/2023	NEW	$581,891
														Subtotal = $581,891

Grand Total All Awards = $2,200,827

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Contributions of prion strains and substrains to prion zoonotic potential and evolution

Award Number: R01NS133050

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2023

PERIOD OF PERFORMANCE END DATE: 06/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer